Effects of silymarin on biochemical and oxidative stress markers in end‐stage renal disease patients undergoing peritoneal dialysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1542-4758|20|4|558-563

ISSN： 1492-7535

Source： Hemodialysis International, Vol.20, Iss.4, 2016-10, pp. : 558-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prevalence of Carotid Artery Calcification on the Panoramic Radiographs of End-stage Renal Disease Patients with Peritoneal Dialysis: Do Incidental Findings Provide Life-saving Information?

By Gokce C   Sisman Y   Sipahioglu M   Ertas ET   Akgunlu F   Unal A   Tokgoz B   Oymak O   Utas C  

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 47-53

Field House Publishing

Access to resources Recommend Favorite

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

By  

Current Drug Metabolism, Vol. 12, Iss. 1, 2011-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K   Zussman B   Miller AK   Freed MI  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

Epidemiology of end-stage renal disease

By Roderick Paul  

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 200-204

Royal College Of Physicians

Access to resources Recommend Favorite

Pathophysiology and Treatment of Hyperhomocysteinemia in End‐Stage Renal Disease Patients

By  

Hemodialysis International, Vol. 5, Iss. 1, 2001-01 ,pp. : 86-91

John Wiley & Sons Inc

Access to resources Recommend Favorite